BDBM229576 US9334279, 1052

SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cscn1

InChI Key InChIKey=VQERXQQMVXRWMN-LEXPNQKKSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 229576   

TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229576(US9334279, 1052)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229576(US9334279, 1052)
Affinity DataEC50:  0.300nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent